Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: Role of CB1 receptors

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 47, Issue , 2013, Pages 77-84

  Rodríguez Arias, Marta ^a   Valverde, Olga ^b   Daza Losada, Manuel ^a   Blanco Gandía, M Carmen ^a   Aguilar, María A ^a   Miñarro, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

CB1 receptor; Conditioned place preference; Knockout mice; MDMA

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABINOID 1 RECEPTOR; CARRIER PROTEIN; DOPAMINE; MONOAMINE TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; MAZE TEST; MOUSE; NEUROCHEMISTRY; NONHUMAN; PLACE PREFERENCE; PROTEIN FUNCTION; TRANQUILIZING ACTIVITY;

3,4-DIHYDROXYPHENYLACETIC ACID; 3,4-METHYLENEDIOXY-METHAMPHETAMINE; 5-HIAA; 5-HT; 5-HYDROXYINDOLEACETIC ACID; CB1 KNOCKOUT; CB1 RECEPTOR; CONDITIONED PLACE PREFERENCE; CPP; DA; DAT; DELTA-9-TETRAHIDROCANNABINOL; DITHIOTHREITOL; DOPAC; DOPAMINE; DOPAMINE TRANSPORTER; DTT; EDTA; ELEVATED PLUS MAZE; EPM; ETHANOL; ETHYLENEDIAMINETETRAACETIC ACID DISODIUM SALT DEHYDRATE; ETOH; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOVANILLIC ACID; HPLC; HVA; KNOCKOUT MICE; KOCB1; MDMA; N. ACC; NUCLEUS ACCUMBENS; PFC; POST-C; POST-CONDITIONING PHASE; PRE-C; PRE-CONDITIONING PHASE; PREFRONTAL CORTEX; SEROTONIN; SEROTONIN TRANSPORTER; SERT; THC; WILDTYPE; WT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; HOMOVANILLIC ACID; MALE; MAZE LEARNING; MICE; MICE, KNOCKOUT; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84884130258     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.07.013     Document Type: Article

References (47)

1. Aguilar M.A., Rodríguez-Arias M., Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Rev 2009, 59:253-277.
2. Aso E., Renoir T., Mengod G., Ledent C., Hamon M., Maldonado R., et al. Lack of CB1 receptor activity impairs serotonergic negative feedback. J Neurochem 2009, 109:935-944.
3. Bilkei-Gorzo A., Racz I., Valverde O., Otto M., Michel K., Sastre M., et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci 2005, 102:15670-15675.
4. Braida D., Sala M. Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. Br J Pharmacol 2002, 136:1089-1092.
5. Braida D., Iosuè S., Pegorini S., Sala M. 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system. Pharmacol Res 2005, 51:177-182.
6. Castañé A., Valjent E., Ledent C., Parmentier M., Maldonado R., Valverde O. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 2002, 43:857-867.
7. Colombo G., Serra S., Brunetti G., Gomez R., Melis S., Vacca G., et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl) 2002, 159:181-187.
8. Cossu G., Ledent C., Fattore L., Imperato A., Bohme G.A., Parmentier M., et al. Cannabinoid CB1 receptor knockout mice fail to self administer morphine but not other drugs of abuse. Behav Brain Res 2001, 118:61-65.
9. Daza-Losada M., Ribeiro Do Couto B., Manzanedo C., Aguilar M.A., Rodriguez-Arias M., Miñarro J. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 2007, 32:1750-1759.
10. Daza-Losada M., Rodríguez-Arias M., Aguilar M.A., Miñarro J. Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence. Addict Biol 2009, 14:447-456.
11. Daza-Losada M., Miñarro J., Aguilar M.A., Valverde O., Rodríguez-Arias M. Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference. Pharmacol Biochem Behav 2011, 100:33-39.
12. Fattore L., Martellotta M.C., Cossu G., Mascia M.S., Fratta W. CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 1999, 104:141-146.
13. George J., Kinner S.A., Bruno R., Degenhardt L., Dunn M. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use. Drug Alcohol Rev 2010, 29:243-249.
14. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 1999, 2:358-363.
15. Haller J., Bakos N., Szirmay M., Ledent C., Freund T.F. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 2002, 16:1395-1398.
16. Haller J., Varga B., Ledent C., Barna I., Freund T.F. Context-dependent effects of CB1cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 2004, 19:1906-1912.
17. Heffner T.G., Hartman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 1980, 13:453-456.
18. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
19. Maccarrone M., Valverde O., Barbaccia M.L., Castañé A., Maldonado R., Ledent C., et al. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 2002, 15:1178-1186.
20. Manzanedo C., Aguilar M.A., Rodríguez-Arias M., Navarro M., Miñarro J. Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport 2004, 15:1373-1377.
21. Manzanedo C., Rodríguez-Arias M., Daza-Losada M., Maldonado C., Aguilar M.A., Miñarro J. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behav Brain Funct 2010, 6:19.
22. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 2000, 12:4038-4046.
23. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 2002, 159:379-387.
24. Orejarena M.J., Lanfumey L., Maldonado R., Robledo P. Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. Int J Neuropsychopharmacol 2011, 14:927-940.
25. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986, 24:525-529.
26. Piomelli D. The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 2005, 6:672-679.
27. Ratzenboeck E., Saria A., Kriechbaum N., Zernig G. Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 2001, 62:138-144.
28. Ribeiro Do Couto B., Daza-Losada M., Rodríguez-Arias M., Nadal R., Guerri C., Summavielle T., et al. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement. Addict Biol 2012, 17:588-600.
29. Robledo P., Balerio G., Berrendero F., Maldonado R. Study of the behavioural responses related to the potential addictive properties of MDMA in mice. Naunyn Schmiedebergs Arch Pharmacol 2004, 369:338-349.
30. Robledo P., Trigo J.M., Panayi F., de la Torre R., Maldonado R. Behavioural and neurochemical effects of combined MDMA and THC administration in mice. Psychopharmacology (Berl) 2007, 195:255-264.
31. Rodgers R.J. Animal models of 'anxiety': where next?. Behav Pharmacol 1997, 8:477-496.
32. Rodríguez-Arias M., Manzanedo C., Roger-Sánchez C., Do Couto B.R., Aguilar M.A., Miñarro J. Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:166-171.
33. Schenk S., Gittings D., Johnstone M., Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 2003, 169:21-27.
34. Schenk S., Hely L., Gittings D., Lake B., Daniela E. Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats. Drug Alcohol Depend 2008, 96:249-255.
35. Schenk S., Gittings D., Colussi-Mas J. Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. Br J Pharmacol 2011, 162:1770-1780.
36. Solinas M., Panlilio L.V., Tanda G., Makriyannis A., Matthews S.A., Goldberg S.R. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats. Neuropsychopharmacology 2005, 30:2046-2057.
37. Soria G., Mendizábal V., Touriño C., Robledo P., Ledent C., Parmentier M., et al. Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 2005, 30:1670-1680.
38. Thanos P.K., Dimitrakakis E.S., Rice O., Gifford A., Volkow N.D. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 2005, 164:206-213.
39. Thiemann G., Watt C.A., Ledent C., Molleman A., Hasenöhrl R.U. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav Brain Res 2009, 200:60-67.
40. Touriño C., Ledent C., Maldonado R., Valverde O. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement. Biol Psychiatry 2008, 63:1030-1038.
41. Trigo J.M., Panayi F., Soria G., Maldonado R., Robledo P. A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology (Berl) 2006, 184:212-220.
42. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
43. UNODC World Drug Report http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html.
44. Urigüen L., Perez-Rial S., Ledent C., Palomo T., Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004, 46:966-973.
45. Valjent E., Mitchell J.M., Besson M.J., Caboche J., Maldonado R. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 2002, 135:564-578.
46. Varvel S.A., Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 2002, 301:915-924.
47. Zarrindast M.R., Nouri M., Ahmadi S. Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP. Brain Res 2007, 1163:130-137.